JPWO2020096986A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020096986A5
JPWO2020096986A5 JP2021524032A JP2021524032A JPWO2020096986A5 JP WO2020096986 A5 JPWO2020096986 A5 JP WO2020096986A5 JP 2021524032 A JP2021524032 A JP 2021524032A JP 2021524032 A JP2021524032 A JP 2021524032A JP WO2020096986 A5 JPWO2020096986 A5 JP WO2020096986A5
Authority
JP
Japan
Prior art keywords
population
til population
tils
expansion
apcs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021524032A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512915A5 (https=
JP2022512915A (ja
JP7854297B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/059716 external-priority patent/WO2020096986A2/en
Publication of JP2022512915A publication Critical patent/JP2022512915A/ja
Publication of JPWO2020096986A5 publication Critical patent/JPWO2020096986A5/ja
Publication of JP2022512915A5 publication Critical patent/JP2022512915A5/ja
Application granted granted Critical
Publication of JP7854297B2 publication Critical patent/JP7854297B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021524032A 2018-11-05 2019-11-04 改良された腫瘍反応性ｔ細胞の選択 Active JP7854297B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201862756006P 2018-11-05 2018-11-05
US62/756,006 2018-11-05
US201962826831P 2019-03-29 2019-03-29
US62/826,831 2019-03-29
US201962903629P 2019-09-20 2019-09-20
US62/903,629 2019-09-20
US201962924602P 2019-10-22 2019-10-22
US62/924,602 2019-10-22
PCT/US2019/059716 WO2020096986A2 (en) 2018-11-05 2019-11-04 Selection of improved tumor reactive t-cells

Publications (4)

Publication Number Publication Date
JP2022512915A JP2022512915A (ja) 2022-02-07
JPWO2020096986A5 true JPWO2020096986A5 (https=) 2022-11-14
JP2022512915A5 JP2022512915A5 (https=) 2022-11-14
JP7854297B2 JP7854297B2 (ja) 2026-05-01

Family

ID=

Similar Documents

Publication Publication Date Title
US20230287120A1 (en) Dll3 targeting chimeric antigen receptors and binding agents
KR102853978B1 (ko) 제3 신호 수용체를 포함하는 키메릭 항원 수용체 및 이의 용도
CN115052902B (zh) 淋巴细胞-抗原提呈细胞共刺激因子及其应用
JP2021515566A5 (https=)
JP7664180B2 (ja) リツキシマブ耐性キメラ抗原受容体およびその用途
Sharma et al. Immunotherapy of cancer
CN112426526A (zh) 一种nk细胞的制备方法及其在治疗癌症中的应用
US20220249559A1 (en) Methods and compositions for selecting tumor infiltrating lymphocytes and uses of the same in immunotherapy
WO2023020474A1 (en) Bcma targetting antibodies and uses thereof in cancer therapies
US20250171731A1 (en) Methods of manufacturing allogeneic car t cells
CN109021114A (zh) 联合两种单链抗体的双特异性嵌合抗原受体及表达载体
WO2008091643A2 (en) In vitro culture system to evaluate synergy in targeting immune suppressive pathways concurrent to immunotherapy
JPWO2020096986A5 (https=)
JPWO2021226085A5 (https=)
CN118126194A (zh) 靶向cd70的嵌合抗原受体
CN109306013A (zh) 抗cd20抗原的嵌合抗原受体及其应用
US20240216430A1 (en) Claudin 18.2 targeting chimeric antigen receptors and binding agents and uses thereof
EP4545085A1 (en) Car t-cells against cd79b for the treatment of non-hodgkin lymphoma
TWI917318B (zh) 靶向ｄｌｌ３的嵌合抗原受體和結合劑
CN121248779A (zh) 靶向人cd3分子的抗体及其应用
CN119462934A (zh) 一种泛肿瘤抗原抗体d2及其应用
HK40063038B (zh) 靶向dll3的嵌合抗原受体和结合剂
HK40063038A (en) Dll3 targeting chimeric antigen receptors and binding agents
RU2019143419A (ru) Химерные антигенные рецепторы, нацеленные на flt3